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Background: Bovine herpes virus type 1 (BHV-1) still causes great economic loss to the livestock industry and trade
because there aren’t any available drugs that proved to be fully effective against it. In this study, the cytotoxicity
and the antiviral activities of the Thymus capitata extracts were evaluated for the development of new, non toxic
and specific anti-herpesvirus drug. Aqueous extracts (AE), ethanolic extracts (EE) and essential oil (EO) of the aerial
parts of Thymus capitata were analyzed to determine their chemical compositions by gas chromatography, and
high performance liquid chromatography combined with mass spectrometry. Their cytotoxicity and antiviral activities
against Bovine Herpesvirus type 1 (BHV-1) were evaluated by quantifying the reduction of the viral cytopathic effect
using Madin-Darby Bovine Kidney cell line with colorimetric assay. T. capitata extracts were added at different stages of
the viral infection to investigate and better quantify their potential inhibitory effects.
Results: Polyphenols and flavonoids were the major compounds found in T. capitata EO, EE and AE. The cytotoxic
concentrations at 50% were 48.70, 189 and 289 μg ml−1 for EO, EE and AE, respectively. The inhibitor concentrations at
50% for the EO, EE and AE, were 3.36, 47.80 and 164 μg ml−1, respectively. The selectivity index anti-BHV-1 values were
14.49, 3.95 and 1.81 for EO, EE and AE, respectively. Thus, the EO extracts were the most efficient antiviral compounds.
T. capitata extracts affect mainly the adsorption of BHV-1 virus to host cells.
Conclusion: T. capitata extracts inhibit the viral replication by interfering with the early stages of viral adsorption and
replication. Thus, T. capitata is a potential candidate for anti-herpesvirus treatment.
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Bovine herpesvirus type 1 (BHV-1), a member of the sub-
family Alphaherpesvirinae, is a virulent pathogen causing
significant economic losses to the livestock industry,
worldwide [1]. The virus is associated with a variety of
symptoms including rhinotracheitis, vulvovaginitis, balano-
posthitis, abortions, conjunctivitis and generalized systemic
infections [2]. Infectious bovine rhinotracheitis (IBR), a
wide spread enzootic herpetic infection caused by BHV-1,
is classified in the list B of diseases by the Office Inter-
national des Epizooties [2]. BHV-1-induced immunosup-
pression leads frequently to secondary bacterial infections.* Correspondence: ramzi.b.landolsi@gmail.com
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article, unless otherwise stated.Thus, BHV-1 is an important cofactor in the bovine re-
spiratory disease complex which has great financial im-
pacts [1,2]. Furthermore, BHV-1 has received increasing
attention as a surrogate model for anti-herpes virus drug
screenings. On the other hand, plant-derived antiviral ex-
tracts are of great interest for the development of new,
non-toxic, more effective and specific anti-herpesvirus ac-
tive molecules. Indeed, several trials using plant extracts
have shown in vitro anti-BHV-1 activities at early and/or
late stages of the viral replication, such as: Phyllanthus
orbicularis [3], Erythroxylum deciduum, Lacistema has-
slerianum (chodat), Xylopia aromatica [4], Heteropteris
aphrodisiaca [5], Acacia nilotica (gum arabic tree) [6],
Lippia graveolens (Mexican oregano or redbrush lippia)
[7], Guettarda angelica (Velvetseed) [8], Prunus myrtifolia
(West Indian cherry), Symphyopappus compressus [9], and
Pimpinella anisum (Anise) [10].ioMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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also examined for their potential antiviral activity against
herpesvirus, such as: Melissa officinalis (lemon balm),
Mentha piperita (pepper-mint), Prunella vulgaris (pru-
nella), Rosmarinus officinalis (rosemary), Salvia officinalis
(sage) and Thymus vulgaris (thyme) [11-14]. Besides, dif-
ferent thyme species have been screened for antibacterial,
anthelmintic, antifungal and antioxidant activities, and
as immune modulator [15,16]. However, to the best of
our knowledge, cytotoxic and antiviral activities of different
T. capitata (Order of Lamiales, Family of Lamiaceae)
extracts against BHV-1 have never been tested.
In the present study, we have determined the chemical
compositions and the cytotoxicity effects of different ex-
tracts of the T. capitata areal parts, collected in Matmata
region (Southern Tunisia). The aqueous (AE) and ethanolic
extracts (EE) and the essential oil (EO) were tested, since
significant differences in antimicrobial activities between
these extracts have been previously reported [11,12].
Methods
Collection and preparation of the plant materials
Fresh T. capitata plants were collected in June 2011
from Matmata locality in the South East of Tunisia (33°
32′ North 9°58′ East). Aerial parts of the plants (leaves,
stems and flowers) were separated, thoroughly rinsed in
running tap water and air dried at room temperature
during 14 days, then pulverized, grounded to fine pow-
der and stored at +4°C until use.
Preparation of the extracts
The AE and EE were prepared as previously described
by Boubaker Elandalousi et al. [16]. The EO was prepared
by dissolving 100 g of dried plant material in 1 liter of dis-
tilled water, and then submitted to microwave-assisted
hydro-distillation at +40°C during 4 hours, in a Clevenger-
type apparatus.
Stock solution (10 mg ml−1) of EO and EE were dis-
solved in Dulbecco’s modified Eagle’s cell culture medium
(DMEM) with 0.5% dimethylsulfoxide (DMSO). All ex-
tracts were sterilized by filtration (0.22 mm filter), dried
and kept in dark flask at +4°C until tested.
Analyses of T. capitata EO, EE and AE compositions
EO and EE gas chromatography/mass spectrometry (GC/MS)
analysis
The GC-MS unit consists on a Perkin-Elmer Autosys-
tem XL gas chromatograph, equipped with HP-5MS
fused-5% Phenyl Methyl Siloxane capillary column (Agilent,
30 m×0.25 mm, film thickness 0.25 μm). It is interfaced
with Perkin-Elmer Turbo mass spectrometer at specific
operating conditions (injector temperature: 250°C; carrier
gas: Helium adjusted to a linear velocity of 37 cm s−1; flow
rate: 1 ml min−1; volume of injected sample: 1 μl; splitratio: 50:1; ionization energy: 70 Ev; ion source
temperature: 200°C; scan mass range m z−1: 50–550 and
interface line temperature: 300°C).
AE high performance liquid chromatography/mass
spectrometry (HPLC/MS) analysis
HPLC-MS (Agilent, Waldbronn, Germany) separation
was performed using an Agilent C18 reverse-phase col-
umn (150×4.6 mm) which was maintained at 33°C, with
a direct injection of 25 μl of the extract at a 100 bars
pressure and a flow rate of 0.25 ml min−1. Elution was
performed by gradient mode, using water and acetic acid
(999/1 v/v), and acetonitrile in mobile phases. The gradi-
ent program was set to 5% for the 5 first minutes, in-
creased linearly to 100% for 65 minutes, remained at
100% for three minutes and decrease to 5% during the
last 69 minutes. Chromatographic peaks were investi-
gated with Mass Lynx Software (Waldbronn, Germany).
The Mass spectroscopy (MS) was performed using a
Micro mass Quattro Ultima PT MS model (Waldbronn,
Germany) at the following operating conditions: capillary
voltage (3.20 kV); capillary temperature (300°C); multiplier
(550 V) and cone gas flow (60 L Hr−1). The ion trap de-
tector with electro-spray ionization source was used for
quantification, and it was set in negative ionization mode.
Extracts constituents were identified by comparing their
mass spectra or retention indices as HPLC-MS spectra
with those of reference chemical compounds gathered
from the Institut National de Recherches et d’Analyses
Physico-chimiques, Tunisia - LMS library, and commer-
cially available standards from published libraries.
Cell line
Monolayer cultures of MDBK cell line were grown in DMEM
supplemented with 10% fetal calf serum, 100 IU ml−1
penicillin G and 100 mg ml−1 streptomycin. Two hun-
dreds microliters of 1×106 ml−1 cell suspension were put
into each well of a 96-well culture plate, for both cytotox-
icity and antiviral assays. All plates were maintained in an
incubator at 37°C and 5% CO2 atmosphere.
Virus
Stock virus of the Cooper-1 (Colorado-1) strain of BHV-1,
obtained from the American Type Culture Collection
(Rockville, MD, USA), was propagated in MDBK cell cul-
tures. The infected cell supernatant fluids were harvested,
titrated and stored at −80°C until use.
For the virus titration, MDBK cells were seeded in
24-well culture plate and incubated at 37°C. After 24 hours,
serial dilutions of the virus stock were prepared in culture
medium, and each dilution was added to 4 wells. After an
additional 72 hours of incubation, the cytopathic effect
(CPE) in each well was recorded. The viral Titer of BHV-1
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previously [17].
Cytotoxicity assays
To examine the effect of T. capitata extracts on the
growth and the viability of the cultured cells, serial dilu-
tions of extracts (from 5 to 500 μg ml−1) were prepared in
DMEM, in triplicate, and 200 μl of each dilution was
added to the 96-well culture plates. The maximum non-
toxic concentration (MNTC) was determined by cell
morphology alterations, estimated under a light micro-
scope at ×100 magnifications during the 3 days incubation
at 37°C. Monolayer cells incubated with only DMEM were
used as cell controls. The cells were fixed with 1% glutar-
aldehyde for 10 min, stained with 0.1% crystal violet dur-
ing 30 min, and the optical density was determined by a
spectrophotometer at 620 nm wavelength. The cell viabil-
ity was calculated using the following formula:




The 50% cytotoxic concentration (CC50) was calcu-
lated as the concentration causing 50% cell death.
Antiviral assays
Only non cytotoxic and antiviral concentrations of each
plant extract below the MNTC (EO: 2, 3, 4 and 5 μg ml−1;
EE: 50, 55 and 60 μg ml−1 and AE: 160, 170 and 180 μg ml−1)
were tested to assess anti-BHV-1 activity.
To elucidate the mode of antiviral action, the MDBK
cells were incubated with various plant extracts for 3
days, following 3 scenari: before and after viral infection,
simultaneous infection.
Cell culture pretreatment (before infection)
Pre-treatment of cell cultures was performed by expos-
ing the cell monolayers to different concentrations of
the test compounds in maintenance medium (200 μl) for
2 hours at 37°C. After treatment, the cell monolayers
were washed thoroughly with phosphate buffered saline
(PBS), infected with 200 μl BHV-1 suspension at 103 Tissue
Culture Infective Dose 50% (TCID50) ml
−1 of virus and
observed for viral cytopathic activity during 72 hours
incubation.
Inhibition of virus attachment (simultaneous infection)
assay
BHV-1 suspension at a viral concentration of 103TCID50
ml−1 of virus was mixed (v/v: 100 μl) with different con-
centrations of the test extracts at room temperature.Then, cells were incubated immediately with 200 μl of the
mixtures for 72 hours at 37°C and 5% CO2 atmosphere.
Post-infection assay
Two hundred microliters of viral suspension at 103
TCID50 ml
−1 in culture medium were adsorbed to
MDBK cells for 2 hours at 37°C. Cells were then washed
with PBS, and the medium was replaced with 200 μl
DMEM containing the EO, EE and AE of T. capitata at
serial dilutions, which were then incubated for 72 hours
at 37°C and 5% CO2 atmosphere.
The controls consisted of untreated infected cells for
virus control, confluent monolayer cells were infected
with the virus at 103 TCID50 ml
−1 of virus; treated unin-
fected cells for plant extract controls; and untreated un-
infected cells for cell control. After 3 days of incubation,
the optical density (OD) was determined as previously
described. The level of antiviral activity of the plant ex-
tracts was calculated using the following formula:
Antiviral activity %ð Þ ¼ 100 Abssample– Absvirus control
 
= Abscell control– Absvirus controlð Þ
The absorbance (Abs) of the virus control was calcu-
lated by mixing 100 μl ×103 TCID50 of virus suspension
with 100 μl of culture medium without plant extracts.
The absorbance of cell controls was estimated by mixing
100 μl of MNTC of each extracts with 100 μl of culture
medium [18]. The 50% effective antiviral concentration
(IC50) was calculated as the antiviral concentration caus-
ing 50% inhibition of virus-induced CPE. The selectivity
index (SI) was calculated as the ratio of CC50 and IC50.
Statistical analysis
The data are presented as means ± standard deviation
(S.D). The T-test was used to compare differences be-
tween mean groups. A correlation test between concen-
tration extracts and viral inhibition was also performed.
A p-value < 0.05 was considered to imply statistical sig-
nificance. The statistical analysis were performed using
the R software for statistical computing (v3.01, available
from: www.r-project.org), and GraphPad Prism soft-
ware®, release 3.0.
Results
The results of the chemical composition and the cytotoxic
and antiviral activities of each plant extract are presented
in Tables 1, 2, and 3, respectively.
Chemical analysis of Thymus capitata EO, EE and AE
A total number of 28 components were identified in T.
capitata EO; phenols were the major constituents, mainly
the 3-Methyl-4-isopropylphenol: thymol (73.38%). Other
Table 1 List of chemical compounds (descending order)
in essential oil and ethanolic extract identified by GC–MS









73.38 71.22 Apigenin-6,8- di
C-glucoside
Camphor ND 17.18 Luteolin-7-
rutinoside
Benzene 10.86 6.32 Hesperidin
Caryophyllene 2.55 1.11 Apigenin-7-
glucoronide
Linalool 1.97 ND Eupafolin-
glucoside
Caryophyllene oxide 1.87 0.98 Acethyl- luteolin-
glucuronide






Dimethyl Sulfoxide 0.56 ND
(+)-4-Carene 0.50 ND

















Trans-Linalool oxide 0.05 ND





Table 2 Cytotoxic activities of essential oil, ethanolic and
aqueous extracts of Thymus capitata
Concentration
(μg ml−1)







5 100 ± 1.03 95.63 ± 3.31 NA
10 93.50 ± 1.13 93.18 ± 3.87 NA
20 84.51 ± 1.59 96.05 ± 2.87 NA
50 47.42 ± 0.64 92.83 ± 3.27 100 ± 0.74
100 14.77 ± 0.07 79.61 ± 3.64 92.21 ± 2.41
200 2.91 ± 0.03 45.83 ± 1.90 74.20 ± 1.71
300 1.63 ± 0.05 28.97 ± 1.90 48.35 ± 1.21
500 1.21 ± 0.04 26.80 ± 1.47 28.68 ± 0.38
NA: Not applicable.
Table 3 Antiviral activities of selected Thymus capitata
extracts against bovine herpesvirus type1
Extract Yielda (%) CC50
b (μg ml−1) IC50
c (μg ml−1) SId
Essential oil 1 48.70 3.36 14.49
Ethanolic extract 10.05 189 47.80 3.95
Aqueous extract 3.25 298 164 1.81
a% w/w = g of extracts 100 g−1 of dried and ground plant material.
bCytotoxic concentration 50%; c: inhibitor concentration 50%;
dSelectivity index = CC50/IC50.
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tions such as caryophyllene (sesquiterpene, 2.55%), linal-
ool (monoterpene, 1.97%), eugenol (phenol, 0.81%) and
borneol (monoterpene, 0.78%). Aromatic hydrocarbons(benzene, naphthalene, anthracen) and terpens (myrecen,
caren) were also present in T. capitata EO with lower
concentrations (Table 1).
Twelve compounds were identified in EE; most of them
were phenols such as 3-Methyl-4-isopropylphenol or
thymol (71.22%), camphor (17.18%), benzene (6.32%)
and caryophyllene (1.11%) (Table 1).
Apigenin and luteolin derivatives were the most abun-
dant phenolic compounds (flavonoid) found in AE, whilst
rosmarinic acid was a minor one (Table 1).
Several phenolic components were present with roughly
the same concentrations in both EO and EE, mainly
3-Methyl-4-isopropylphenol: thymol (73.38% and 71.22%,
respectively) followed by benzene (10.86% and 6.32%,
respectively).
Cytotoxicity
To examine the effect T. capitata extracts on the growth
and the viability of cultured cells, EO, EE and AE were
serially diluted and added to cell culture medium
(Figure 1A).
The cytotoxicity effect was characterized by aggrega-
tion of degenerated cell clusters detaching from the bot-
tom of the wells forming holes (gap formation) within
the cell monolayer (Figure 1C). The results of cytotoxic
effects of each plant extract are represented in Table 2.
No effect was observed at the concentrations varying
from 5 to 10 μg ml−1 for EO, 10 to 100 μg ml−1 for EE
Figure 1 Cytotoxicity and cytopathic effects on Madin-Darby Bovine Kidney cells (×100) after addition of EO, EE and EA of Thymus
capitata before infection with 103 TCID50 ml
−1 of Bovine herpesvirus type 1 (BHV-1). A: Cell control, not infected with BHV-1, after 72 hours
of incubation. B: Virus control (cytopathic effect), untreated MDBK cell culture, 72 hours after BHV-1 infection with 103 TCID50 ml
−1. C: Cytotoxic
effect, MDBK treated with extracts of EO (50 μg ml−1), 72 hours of incubation. D: Viral inhibition, MDBK cells were pre-treated with EO (5 μg ml−1)
for 2 h, then infected with BHV-1 at 103 TCID50 ml
−1.
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by the colorimetric assay were 48.70 μg ml−1, 189 μg ml−1
and 298 μg ml−1 for EO, EE and AE, for concentrations
up to 10, 100 and 200 μg ml−1 of EO, EE and AE, respect-
ively. Cytotoxicity was detected when degenerated cells
become round and float in the medium with more prom-
inent nuclei. The EO induced the highest cytotoxic effect,
while EE and AE induced moderate and low cytotoxicity
effect, respectively.Virus inhibition
The viral CPE usually appeared within 3 days after in-
oculation. The CPE of BHV-1 is characterized by cell
rounding and ballooning, forming grape-like clusters of
spherical cells gathered around a gap in the monolayer.
Sometimes, giant cells with several nuclei may be ob-
served (Figure 1B).
At MNTC of plant extracts, viral CPE was significantly
reduced (p-values < 0.05) and the anti-BHV-1 activity
showed a dose dependant response (Figure 2A and B).
The IC50 were 3.36, 47.8 and 164 μg ml
−1 for EO, EE
and AE, respectively. According to the SI values, the
highest antiviral activity was seen with EO followed by
that of EE and AE (Table 3). Indeed, a high cytotoxic value
and a low inhibitory concentration gave the highest select-
ivity index for EO, indicating that it is the most effective
antiviral extract (Table 3).When host cells were treated with extracts prior to
infection, no CPE of t BHV-1 infection was observed
(Figure 1D). Thus, pre-treatment of MDBK cells with
T. capitata EO, EE and AE completely inhibited BHV-1
infectivity (p-value < 0.05). However, when T. capitata
EO, EE or AE were added during or after virus penetra-
tion, the viral CPE of the BHV-1 was significantly reduced
in a dose dependant manner (p-value < 0.05) (Figure 2A; B).
A very significant correlation was found between AE
concentration and viral inhibition in the interval [160,
180 μg ml−1] of AE concentration.
Discussion
The analyses of the composition of EO, EE and AE of
Tunisian T. capitata revealed the predominance of
phenolic compounds (Table 1). Thymol: 3-Methyl-4-
isopropylphenol was the major component found in both
EO and EE. Caryophyllene was present in low concentra-
tions in EO and EE. However, camphor, linalool, eugenol
and borneol were only identified in EE and EO, respect-
ively. Interestingly, AE exhibited the largest amount of
apigenin- and luteolin as phenolic (flavones) compounds.
In contrast, rosmarinic acid was found to be a minor com-
pound in AE (Table 1). These findings are in accordance
with those reported in previous studies on T. capitata
from South Tunisia and other countries [14,19]. Mkaddem
et al. [19] showed that the major EO compound in T.
capitata was thymol, using plants from the same region.
Figure 2 Percentage of viral inhibition by different Thymus
capitata extracts: Essential oil (2, 3, 4 and 5 μg ml−1), Ethanolic
extract (50, 55 and 60 μg ml−1) and Aqueous extract (160, 170
and 180 μg ml−1) were tested during (A) and after (B) infection
of MDBK cells with 103 TCID50 ml
−1 of Bovine herpesvirus
type 1.
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crol were the major compounds in T. capitata EO from
Iran. However, other studies showed geographic variations
of chemical compositions of T. capitata extracts [15,20].
Nolkemper et al. [11] found that rosmarinic acid was the
most abundant compound of the same genus T. vulgaris
AE. In fact, bioactive molecule types and amount varia-
tions from T. capitata depend on the geographic distribu-
tion (climate, soil type), the collecting season, as well as,
the plant part [20,21].
In the present study, T. capitata extracts exhibited an
in vitro cytotoxic activity with CC50 values varying from
48.70 to 298 μg ml−1, depending on the type used in the
same biological conditions (Table 2). When referring to
the in vitro and the predicted in vivo substance toxicity
classification of Halle and Göres [22], T. capitata EO, EE
and AE are considered to exhibit a relatively low toxicity;
the most toxic extract being EO.
Cytotoxic activities of EO or its major components
were demonstrated, in vitro, in mammalian cells to be
moderate to high [22]. Indeed, EO induced some defectsin the cell respiratory system (permeabilization of outer
and inner mitochondrial membranes), usually directly as-
sociated with cell death by apoptosis and necrosis [23]. In
general, the cytotoxic activity of EO is mostly due to the
presence of phenols. However, flavones are the cytotoxic
components present in AE and have been reported to ex-
hibit cytotoxic activity at high concentrations towards nor-
mal non infected human cells [24]. Furthermore, it has
been suggested that when flavonoids are introduced into
cells, they increase the intracellular reactive oxygen spe-
cies levels, and exert their cytotoxicity effect [24]. Accord-
ing to previous studies, CC50 values of T. vulgaris were 70,
62.3 [12] and 62 μg ml−1 [11] for EO, EE and AE, respect-
ively. The difference in AE chemical compositions be-
tween T. capitata and T. vulgaris may explain the
observed CC50 values. The rosmarinic acid was the most
abundant compound in T. vulgaris. However, for South
Tunisia, T. capitata AE, apigenin and luteolin were the
major compounds and rosmarinic acid was the minor
extracted compound. Nolkemper et al. [11] showed that
for aqueous Lamiaceae plant extracts, the CC50 varied
between 55 and 125 μg ml−1 due to differences in their
phenolic compounds’ concentrations.
In the present study, the inhibitory effect of thyme EO
against BHV-1 infection was compared to the antiviral
activity of EE and AE (Table 3). Both T. capitata extracts
were shown to affect significantly BHV-1 replication
(p value < 0.05). Previous in vitro experiments showed
similar results for EO, EE and AE from Lamiaceae plant
including Thymus spp. [11,12].
The thyme EO revealed a higher antiviral activity and
a SI of 14.49, whereas EE and AE showed lower SIs
(Table 3). The anti-herpes virus activities of several EOs
of different plant sources as well as of some constituents
of EOs were reported previously, e.g. peppermint oil,
thyme oil and anise oil [10,25,26]. The presence of thy-
mol and β-caryophyllene in EO may strongly contribute
to their antiviral effect which is in agreement with our
results and as described by others [14,27].
Pre-treatment of cells with different T. capitata ex-
tracts, at the tested concentrations, completely inhib-
ited viral CPE (Figure 1D). In addition, an antiviral
activity dose dependent effect was significantly observed
(p-value < 0.05) for EO, EE and AE when added during or
after cell infection (Figure 2A; B). A very significant correl-
ation was found between AE concentration and viral in-
hibition in the interval [160, 180 μg ml−1]. These results
suggested that these biomolecules may interfere with ei-
ther viral particles and/or virus envelope, and may mask
viral structures or cell receptors necessary for the virus ad-
sorption and entry into the host cells. In fact, Schnitzler
et al. [13] reported that balm oil, abundant in phenolic
compounds, affected the viruses in vitro when added be-
fore viral adsorption, although the mechanism of action is
Boubaker–Elandalousi et al. BMC Veterinary Research 2014, 10:231 Page 7 of 8
http://www.biomedcentral.com/1746-6148/10/231still unknown. It is suggested that the balm oil could bind
to the viral proteins involved in the host adsorption and
penetration, or damage the virus envelope. In several
cases, plant-derived polyphenols exhibit anti-herpesvirus
activity mostly by influencing the early phases of infection
[18]. Furthermore, Reichling et al. [12] concluded that
ethanolic plant extracts affect herpesvirus prior to and
during adsorption. They suggested that the antiviral ac-
tivity is due to the association of the extracts with pro-
teins of the host cell surface molecules, resulting in
reduction or prevention of viral adsorption.
Flavonoid derivatives have also been reported to possess
antiviral activity against a wide range of viruses [28-30].
Apigenin 7-O-glucoside and luteolin are flavonoid com-
pounds that are found in lemon balm (Melissa officinalis),
chamomile (Chamomilla recutita), and celery (Apium
graveolens) and have shown antiviral activity in vitro
[28,31]. The extracts of basil (Ocimum basilicum) and
their purified compounds, including apigenin, were tested
against a number of viruses (herpesvirus, adenovirus, and
hepatitis B virus), and have displayed a broad range of
antiviral action, which is in accordance with our data [32].
The mechanism of antiviral action of polyphenolic
compounds is mainly due to inhibition of viral enzymes,
disruption of cell receptors, prevention of viral binding
and penetration into cells. Finally, some natural com-
pounds are reported to have the capacity to interfere
with herpesvirus enzymes (DNA polymerase inhibition
by eugenol), and thus viral replication [33].Conclusion
Thymus capitata EO, EE and AE affect (below cytotoxic
concentration) mainly the adsorption of BHV-1 virus to
Madin-Darby Bovine Kidney host cells. This activity can
be explained by the presence of some flavonoids such as
apigenin, luteolin or rosmarinic acid in the AE and the
presence of polyphenols as thymol in EE and EO. During
pre-treatment of MDBK cells, all tested extracts of T. capi-
tata inhibit viral attachment to cell receptors making them
good candidates against viral infection. Moreover, a dose-
dependent effect was recorded during and after viral infec-
tions for the three T. capitata extracts tested.Abbreviations
GC/MS: Gas chromatography–mass spectrometry; HPLC/MS: Performance
liquid chromatography/mass spectrometry; EO: Essential oil; EE: Ethanolic
extract; AE: Aqueous extract; BHV-1: Bovine herpesvirus type 1;
DMEM: Dulbecco’s modified Eagle’s medium; DMSO: Dimethylsulfoxide;
MNTC: Maximum non-toxic concentration; MDBK: Madin-Darby Bovine
Kidney; CPE: Cytopathic effect; TCID50: The 50% Tissue Culture Infective Dose;
IC50: The 50% effective antiviral concentration; CC50: The 50% cytotoxic
concentration; SI: The selectivity index.Competing interests
The authors declare that they have no competing interests.Authors’ contributions
RB-E, MM-T, BK, IL, M-FD, MG, HA, FB, and A-JG designed the study and
participated in plant selection and collection, spectral analyses and in the
drafting and correction of the manuscript., RB-E, MM-T, BK, IL, M-FD, FB and
A-JG performed GC/SM, HPLC/SM analyses of the plant extracts and carried
out the cytotoxicity and antiviral assay. They also contributed to data analysis
and critically revised the manuscript. All the authors read and approved the
final manuscript version.Acknowledgements
This work received financial support from the «Laboratoire d’épidémiologie et
microbiologie vétérinaire », Institut Pasteur of Tunis (Ministère de l’enseignement
supérieur et de la recherche, Tunisia).
Author details
1Université Tunis El Manar, Laboratoire d’Epidémiologie et Microbiologie
Vétérinaire, Institut Pasteur de Tunis, Place Pasteur BP 74, 1002 Tunis, Tunisia.
2Université de la Manouba, Institut Supérieur de Biotechnologie, BiotechPôle,
BP–66, 2020 Sidi Thabet, Tunisia. 3Université de la Manouba, Laboratoire de
Parasitologie, École Nationale de Médecine Vétérinaire de Sidi Thabet, 2020
Sidi Thabet, Tunisia. 4Université de la Manouba, Laboratoire des Substances
Naturelles, Institut National de Recherche et d’Analyse Physico–chimique –
Pôle Technologique Sidi Thabet, 2020 Sidi Thabet, Tunisia.
Received: 1 May 2014 Accepted: 22 September 2014References
1. Biswas S, Bandyopadhyay S, Dimri U, Patra PH: Bovine herpesvirus-1
(BHV-1) – a re-emerging concern in livestock: a revisit to its biology,
epidemiology, diagnosis, and prophylaxis. Vet Quarterly 2013, 33:68–81.
2. Jones C, Chowdhury S: Bovine herpesvirus type 1 (BHV-1) is an important
cofactor in the bovine respiratory disease complex. Vet Clin North Am
Food Anim Pract 2010, 26:303–321.
3. del Barrio G, Parra F: Evaluation of the antiviral activity of an aqueous
extract from Phyllanthus orbicularis. J Ethnopharmacol 2000, 72:317–322.
4. Simoni IC, Manha APS, Sciessere L, Hoe VMH, Takinami VH, Fernandes MJB:
Evaluation of the antiviral activity of Brazilian cerrado plants against
animal viruses. Virus Rev Res 2007, 12:25–31.
5. Melo FL, Benati FJ, Junior WAR, Mello JCP, Nozaw C, Carvalho Linhares RE:
The in vitro antiviral activity of an aliphatic nitro compound from
Heteropteris aphrodisiaca. Microbiol Res 2008, 163:136–139.
6. Gupta D, Goel A, Bhatia AK: Studies on antiviral property of Acacia
nilotica. J Env Res Dev 2010, 5:141–152.
7. Pilau MR, Alves SH, Weiblen R, Arenhart S, Cueto AP, Lovato LT: Antiviral
activity of the Lippia graveolens (mexican oregano) essential oil and its
main compound carvacrol against human and animal viruses. Braz J
Microbiol 2011, 42:1616–1624.
8. Barros AV, Araújo LM, Oliveira FF, Conceição AO, Simoni IC, Fernandes MJB,
Arns CW: In vitro evaluation of the antiviral potential of Guettarda
angelica against animal herpesviruses. Acta Scientiae Veterinariae 2012,
40:1068–1075.
9. Fernandes MJB, Barros AV, Melo MS, Simoni IC: Screening of Brazilian
plants for antiviral activity against animal herpesviruses. J Med Plants Res
2012, 6:2261–2265.
10. Abdallah FM, Sobhy H, Enan G: Evaluation of antiviral activity of selected
anise oil as an essential oil against Bovine herpesvirus type -1 in vitro.
Glob Veterinaria 2013, 10:496–499.
11. Nolkemper S, Reichling J, Stintzing FC, Carle R, Schnitzler P: Antiviral effect
of aqueous extracts from species of the Lamiaceae family against herpes
simplex virus type 1 and type 2 in vitro. Planta Med 2006, 72:1378–1382.
12. Reichling J, Nolkemper S, Stintzing FC, Schnitzler P: Impact of ethanolic
lamiaceae extracts on herpes virus infectivity in cell culture. Forsch
Komplementmed 2008, 15:313–320.
13. Schnitzler P, Schuhmacher A, Astani A, Reichling J: Melissa officinalis oil affects
infectivity of enveloped herpesviruses. Phytomed 2008, 15:734–740.
14. Behravan J, Ramezani M, Nobandegani FE, Gharaee ME: Antiviral and
antimicrobial activity of Thymus transcaspicus essential oil. Pharmacol
Online 2011, 1:1190–1199.
Boubaker–Elandalousi et al. BMC Veterinary Research 2014, 10:231 Page 8 of 8
http://www.biomedcentral.com/1746-6148/10/23115. Jabri–Karoui I, Bettaieb I, Msaada K, Hammami M, Marzouk B: Research on
the phenolic compounds and antioxidant activities of Tunisian Thymus
capitata. J Funct Foods 2012, 4:66–69.
16. Boubaker Elandalousi R, Akkari H, B’chir F, Gharbi M, Mhadhbi M, Awadi S,
Darghouth MA: Thymus capitata from Tunisian arid zone: chemical
composition and in vitro anthelmintic effects on Haemonchus contortus.
Vet Parasitol 2013, 197:374–378.
17. Reed IJ, Muench H: A simple method of estimating fifty per cent
endpoints. Am J Epidemiol 1938, 27:493–497.
18. Chattopadhyay D, Chawla Sarkar M, Chatterjee T, Dey R, Bag P, Chakrabarty
S, Khan MTH: Recent advancements for the evaluation of antiviral
activities of natural products. New Biotechnol 2009, 25:347–368.
19. Mkaddem MG, Romdhane M, Ibrahim H, Ennajar M, Lebrihi A, Mathieu F,
Bouajila J: Essential oil of Thymus capitata Hoff. et Link. from Matmata,
Tunisia: gas chromatography-mass spectrometry analysis and antimicrobial
and antioxidant activities. J Med Food 2009, 13:1500–1504.
20. Saei–Dehkordi SS, Tajik H, Moradi M, Khalighi–Sigaroodi F: Chemical
composition of essential oils in Zataria multiflora Boiss. from different
parts of Iran and their radical scavenging and antimicrobial activity.
Food Chem Toxicol 2010, 48:1562–1567.
21. Loziene K, Venskutonis PR: Influence of environmental and genetic factors
on the stability of essential oil composition of Thymus pulegioides.
Biochem Syst Ecol 2005, 33:517–525.
22. Halle W, Göres E: Prediction of LD50 values by cell culture. Pharmazie 1987,
42:245–248.
23. Bakkali F, Averbeck S, Averbeck D, Idaomar M: Biological effects of
essential oils – a review. Food Chem Toxicol 2008, 46:446–475.
24. Matsuo M, Sasaki N, Saga K, Kaneko T: Cytotoxicity of flavonoids toward
cultured normal human cells. Biol Pharm Bull 2005, 28:253–259.
25. Schuhmacher A, Reichling J, Schnitzler P: Virucidal effect of peppermint oil
on the enveloped viruses herpes simplex virus type 1 and 2 in vitro.
Phytomed 2003, 10:504–510.
26. Koch C, Reichling J, Schneele J, Schnitzler P: Inhibitory effect of essential
oils against herpes simplex virus type 2. Phytomed 2008, 15:71–78.
27. Astani A, Reichling J, Schnitzler P: Screening for antiviral activities of
isolated compounds from essential oils. Evid Base Complement Altern Med
2011, 44:8–15.
28. Akula SM, Hurley DJ, Wixon RL, Wang C, Chase CC: Effect of genistein on
replication of bovine herpesvirus type 1. Am J Vet Res 2002, 63:1124–1128.
29. Nowakowska Z: A review of anti-infective and anti-inflammatory
chalcones. Eur J Med Chem 2007, 42:125–137.
30. Özçelik B, Kartal M, Orhan I: Cytotoxicity, antiviral and antimicrobial
activities of alkaloids, flavonoids, and phenolic acids. Pharm Biol 2011,
49:396–402.
31. Andres A, Donovan SM, Kuhlenschmidt MS: Current Topics Soy isoflavones
and virus infections. J Nutr Biochem 2009, 20:563–569.
32. Chiang LC, Ng LT, Cheng PW, Chiang W, Lin CC: Antiviral activities of
extracts and selected pure constituents of Ocimum basilicum. Clin Exp
Pharmacol Physiol 2005, 32:811–816.
33. Felipe AMM, Rincão VP, Benati FJ, Linhares REC, Galina KJ, de Toledo CEM,
Lopes GC, de Mello JCP, Nozawa C: Antiviral effect of Guazuma ulmifolia
and Stryphnodendron adstringens on poliovirus and bovine herpesvirus.
Biol Pharm Bull 2006, 29:1092–1095.
doi:10.1186/s12917-014-0231-6
Cite this article as: Boubaker–Elandalousi et al.: Non-cytotoxic Thymus
capitata extracts prevent Bovine herpesvirus-1 infection in cell cultures.
BMC Veterinary Research 2014 10:231.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
